Protogenix Inc.

New Filing
CIK: 0002110349·Biotechnology·DELAWARE·Filed: Feb 13, 2026
Total Offering

$4,200,000

Amount Sold

$250,000

Investors

1

First Sale

Dec 24, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)

Related Persons

NameRole
Christopher PJ Wightman
Executive Officer, Director
Eric R Pettee
Executive Officer, Director
Robert Poltrino
Director

Company

Protogenix Inc.

237 TOWER RD

ITHACA, NY, 14853

6075928781

SEC Filing

0002110349-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Protogenix Inc. Form D Filing — $4,200,000 | FilingFlow